Direktorat Registrasi ObatValid

COPAXONE

by '-'

BPOM Number: DKI2462300243A1
Approved: 10 January 2025
Expiry: 30 December 2029
Form: INJEKSI

About This Registration

COPAXONE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2462300243A1. Its current registration status is Valid, with the licence valid until 30 December 2029. The product is registered to ACTAVIS INDONESIA - INDONESIA. BPOM first approved this registration in December 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: PRE-FILLED PEN CONSISTING A PRE-FILLED SYRINGE WHICH CONTAINS 1 ML SOLUTION FOR INJECTION
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

ACTAVIS INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 010005254052000
owner
View profile →

Manufacturing Sites

ACTAVIS INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Market Intelligence

Owner Portfolio: ACTAVIS INDONESIA - INDONESIA holds 164 BPOM registrations
Manufacturer Scale: ACTAVIS INDONESIA - INDONESIA produces 164 registered products
Registration Age: Registered for 1 year, 8 months

FDA Cross-Reference

via openFDA

Generic Name: GLATIRAMER ACETATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: SUBCUTANEOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?